Clinical trial
Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal…
NCT00073710 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00073710 |
|---|---|
| Title | Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium |
| Official title | A Phase IV, Single-Center, Active-Controlled Cross-Over Pilot Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Secondary Hyperparathyroidism, Chronic Kidney Disease |
| Intervention type | Drug, Procedure |
| Interventions | Zemplar, 42 Ca carbonate absorption via single tracer method, Calcijex |
| Enrollment | 30 |
| Start date | Sep 1, 2004 |
| First posted | Dec 4, 2003 |
| Last update posted | Aug 2, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: